Why UNH Stock Is Falling Today

UnitedHealth's Stock Plummets After Disappointing Earnings

Shares of UnitedHealth, a leading health insurance company, experienced a significant drop of 4.6% during the morning trading session. This decline followed the release of second-quarter earnings that fell below expectations and a full-year profit outlook that was far from what analysts had anticipated. The company reported adjusted earnings per share (EPS) for the quarter at $4.08, which was notably lower than the expected $4.48 on Wall Street.

More concerning for investors was the company’s decision to reinstate its full-year guidance after having suspended it in May. UnitedHealth now projects at least $16 in adjusted EPS for 2025, a substantial decrease from previous forecasts and significantly below the over $20 that analysts had expected. The primary factor behind this poor performance was a sharp increase in medical expenses, as reflected in the company's medical care ratio, which rose to 89.4%. This metric indicates the proportion of premiums spent on healthcare services, and the rise is attributed to medical trends outpacing pricing and reductions in Medicare funding.

Market Volatility and Investor Sentiment

The stock market often reacts strongly to news, and significant price drops can present opportunities for investors looking to purchase high-quality stocks. The question remains: is now the right time to buy UnitedHealth?

UnitedHealth’s shares have shown considerable volatility, with 16 instances of moves exceeding 5% over the past year. In this context, today’s drop suggests that the market views the news as meaningful but not a fundamental shift in the company’s long-term prospects.

One of the most notable movements occurred three months ago when the stock fell by 22.9% following disappointing first-quarter results. At that time, the company reported lower-than-expected sales and profits, driven by increased healthcare activity among seniors in its Medicare plans. This surge in activity led to higher costs and negatively impacted profits. Some of these activities were delayed visits that had been postponed during the COVID-19 period. While revenue grew by 10% compared to the previous year, costs increased at a faster rate, causing the medical care ratio to rise. This meant that a larger portion of each dollar was being used to cover claims, and the company anticipated a further increase in this ratio in the near term.

Financial Performance and Long-Term Outlook

The recent earnings report highlighted ongoing challenges for UnitedHealth. The company’s full-year earnings forecast came in well below analyst expectations, primarily due to prolonged issues with care costs in its privately run Medicare plans and funding problems. Despite decent top-line growth, bottom-line pressures and reimbursement risks remain unresolved, casting uncertainty over the company’s earnings outlook.

Since the start of the year, UnitedHealth’s stock has declined by 47.2%, and it is currently trading at $266.59 per share, which is 57.4% below its 52-week high of $625.25 recorded in November 2024. Investors who purchased $1,000 worth of UnitedHealth shares five years ago would now see their investment valued at approximately $869.26.

Opportunities in Thematic Investing

At StockStory, we recognize the potential of thematic investing, where identifying promising growth stories driven by megatrends can lead to substantial returns. Companies like Microsoft (MSFT), Alphabet (GOOG), Coca-Cola (KO), and Monster Beverage (MNST) have all demonstrated strong growth fueled by such trends. In line with this approach, we have identified a relatively under-the-radar profitable growth stock that benefits from the rise of artificial intelligence. This opportunity is available to you for free via the provided link.